Peripheral

Late breaking trials I

Watch this PVI 2024 session replay to dive into the latest late-breaking data in peripheral intervention. 

The programme explores how diabetes, stenosis severity, gender and TASC classification influence CD-TLR and survival in the T.I.N.T.I.N. trial, presents the two-year DEEPER OUS results on retrievable scaffold therapy combined with a paclitaxel-coated balloon, reviews insights from the BIO-OSCAR SOC assessment of current standard-of-care practices for infrainguinal arterial lesions, and highlights the 24-month outcomes of the prospective, multicenter study evaluating the COVERATM PLUS covered stent for iliac artery disease.

Navigate this comprehensive update on emerging evidence across the peripheral field!

Stéphan Haulon
Stéphan Haulon
Hospital: Marie Lannelongue, Le Plessis-Robinson, France
Koen Deloose
Koen Deloose
Dendermonde, Belgium
Hospital: AZ Sint Blasius
Michael Lichtenberg
Michael Lichtenberg
Arnsberg, Germany
Raphael Coscas
Raphael Coscas
Boulogne-Billancourt, FRANCE

You must be logged in or create an account to see all the content